Loading clinical trials...
Loading clinical trials...
National Pandemic Cohort Network - High-resolution Platform (HAP) Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity
Conditions
Locations
11
Germany
University Medical Center Freiburg Department of Internal Medicine II Department of Infectiology
Freiburg im Breisgau, Baden-Wurttemberg, Germany
University Hospital Heidelberg Clinic for Gastroenterology, Infections, Poisoning
Heidelberg, Baden-Wurttemberg, Germany
Clinic of the University of Munich Medical Clinic and Polyclinic III
Munich, Bavaria, Germany
University Hospital Frankfurt Medical Clinic II Department of infectiology
Frankfurt am Main, Hesse, Germany
University Hospital Giessen (+Marburg) Medical Clinic II Pneumology and internal intensive care medicine Infectiology, Gastroenterology, Nephrology
Giessen, Hesse, Germany
Hanover Medical School Clinic for Pneumology
Hanover, Lower Saxony, Germany
Start Date
November 6, 2020
Primary Completion Date
November 1, 2025
Completion Date
November 30, 2025
Last Updated
February 10, 2021
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Charite University, Berlin, Germany
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions